Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure

American Journal of Emergency Medicine

Volumn 34, Issue 2, 2016, Pages 257-262

  Self, Wesley H ^a   Storrow, Alan B ^a   Hartmann, Oliver ^b   Barrett, Tyler W ^a   Fermann, Gregory J ^c   Maisel, Alan S ^d   Struck, Joachim ^b   Bergmann, Andreas ^b   Collins, Sean P ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b SPHINGOTEC GMBH   (Germany)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BIOACTIVE ADRENOMEDULLIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; SODIUM; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIALYSIS; EMERGENCY CARE; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; SODIUM BLOOD LEVEL; BLOOD; CLINICAL TRIAL; HEART FAILURE; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS;

ADRENOMEDULLIN; AGED; BIOMARKERS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84957950517     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2015.10.033     Document Type: Article

References (24)

1. A.B. Storrow, C.A. Jenkins, W.H. Self, P.T. Alexander, T.W. Barrett, J.H. Han, and et al. The burden of acute heart failure on U.S. Emergency departments JACC Heart Fail 2 2014 269 277
2. G.J. Fermann, and S.P. Collins Initial management of patient with acute heart failure Heart Fail Clin 9 2013 291 301
3. E.P. Kransdorf, and M.M. Kittlesson Dissecting the CHF admission: An evidence-based review of the evaluation and management of acute decompensated heart failure for the hospitalist J Hosp Med 7 2012 439 445
4. W. Bereket, K. Hemalatha, B. Getenet, T. Wondwossen, A. Solomon, A. Zeynudin, and et al. Update on bacterial nosocomial infections Eur Rev Med Pharmacol Sci 16 2012 1039 1044
5. E. Joosten, M. Demuynck, E. Detroyer, and K. Milisen Prevalence of frailty and its ability to predict hospital delirium, falls and 6-month mortality in hospitalized older patients BMC Geriatr 14 2014 1
6. J.B. McCausland, M.S. Machi, and D.M. Yealy Emergency physicians' risk attitudes in acute decompensated heart failure patients Acad Emerg Med 17 2010 108 110
7. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, and et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
8. A. Maisel, C. Mueller, R. Nowak, W.F. Peacock, J.W. Landsberg, P. Ponikowski, and et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
9. W.F. Peacock, T. DeMarco, G.C. Fonarow, D. Kiercks, J. Wynne, F.S. Apple, and et al. Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126
10. G.C. Fonarow, K.F. Adams, W.T. Abraham, C.W. Yancy, and W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
11. M. Gheorghiade, W.T. Abraham, N.M. Albert, W. Gattis Stough, B.H. Greenberg, C.M. O'Connor, and et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 2007 980 988
12. M. Gheorghiade, W.T. Abraham, N.M. Albert, B.H. Greenberg, C.M. O'Connor, L. She, and et al. Systolic blood pressure at admission, clinical characteristics and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
13. M. Jougasaki, and J.C. Burnett Jr. Adrenomedullin: potential in physiology and pathophysiology Life Sci 66 2000 855 872
14. M. Jougasaki, C.M. Wei, L.J. McKinley, and J.C. Burnett Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure Circulation 92 1995 286 289
15. C. Adlbrecht, M. Hulsmann, G. Strunk, R. Berger, K. Morti, J. Struck, and et al. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients Eur J Heart Fail 11 2009 361 366
16. A. Maisel, C. Mueller, R.M. Nowak, W.F. Peacock, P. Ponikowski, M. Mockel, and et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Heart Failure) trial J Am Coll Cardiol 58 2011 1057 1067
17. H. Ohta, T. Tsuji, S. Asai, S. Tanizaki, K. Sasakura, H. Teraoka, and et al. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma Clin Chim Acta 287 1999 131 143
18. S. Eguchi, Y. Hirata, H. Iwasaki, K. Sato, T.X. Watanabe, T. Inui, and et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells Endocrinology 135 1994 2454 2458
19. R. Marino, J. Struck, A.S. Maisel, L. Magrini, A. Bergmann, and S. Di Somma Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis Crit Care 18 2014 R34
20. S.P. Collins, C.J. Lindsell, C.A. Jenkins, F.E. Harrell, G.J. Fermann, K.F. Miller, and et al. Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies Am Heart J 164 2012 825 834
21. H. Jneid, J.L. Anderson, R.S. Wright, C.K. Adams, C.R. Bridges, D.E. Casey, and et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 645 648
22. F. Travaglino, V. Russo, B. De Berardinis, F. Numeroso, P. Catania, G. Cervellin, and et al. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial Am J Emerg Med 32 2014 334 341
23. S.P. Collins, and A.B. Storrow Acute heart failure risk stratification: Can we define low risk? Heart Fail Clin 5 2009 75 83
24. I.G. Stiell, C.M. Clement, R.J. Brison, B.H. Rowe, B. Borgundvaaf, S.D. Aaron, and et al. A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events Acad Emerg Med 20 2013 17 26